Antineoplastons, which were first described by Burzynski

“first described by Burzynski”

1995 – Japan – A-10 and AS2-1
http://www.ncbi.nlm.nih.gov/m/pubmed/8667595
Kurume Med J. 1995;42(4):241-9
The Kurume Medical Journal
Vol. 42 (1995) No. 4 P 241-249

Burzynski References: 1 – 3 and 5

1996 – Japan – antineoplaston A10 and AS2-1
http://www.ncbi.nlm.nih.gov/m/pubmed/8755117
Kurume Med J. 1996;43(2):137-47
The Kurume Medical Journal; ISSN:0023-5679; VOL.43; NO.2; PAGE.137-147; (1996)

Burzynski References: 1 – 3

7/3/2000 – Egypt – antineoplaston A-10
http://www.ncbi.nlm.nih.gov/m/pubmed/10814881
Cancer Lett. 2000 Jul 3;155(1):67-70
Cancer Letters Volume 155, Issue 1, Pages 67-70, 3 July 2000

Burzynski References: 3 – 6 and 29

Japan References: 23 – 28

and. amino acid derivatives that control neoplastic growth,. as first described by Burzynski in 1976

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s